$SGHT
Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; and TearCare System, a wearable eyelid technology for the treatment of dry eye disease (DED) for ophthalmologists and optometrists. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. The company was incorporated in 2010 and is headquartered in Menlo Park, California.
Healthcare
Sector
Medical - Devices
Industry
Paul Badawi
CEO
216
Employees
$5.48
Current Price
$300.84M
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 2 weeks | Buys | 0 | 0 | - | - | All Sells |
| Sells | 2 | 2 | $110,991.71 | 20,151 | ||
| 1 month | Buys | 0 | 0 | - | - | All Sells |
| Sells | 6 | 6 | $448,413.13 | 82,750 | ||
| 2 months | Buys | 1 | 1 | $68,793.90 | 14,100 | 1:6.52 |
| Sells | 6 | 6 | $448,413.13 | 82,750 | ||
| 3 months | Buys | 1 | 1 | $68,793.90 | 14,100 | 1:7.47 |
| Sells | 6 | 7 | $513,580.49 | 95,478 | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Jul 6, 2026 | HAYDEN JEREMY B. Chief Legal Officer | Sale | 12,733 | $5.51 | $70,133.36 | View Details |
| Jul 2, 2026 | Rodberg James Chief Financial Officer | Sale | 6,902 | $5.36 | $36,994.72 | View Details |
| Jul 6, 2026 | Badawi David Director | Sale | 7,418 | $5.51 | $40,858.34 | View Details |
| Jul 1, 2026 | Taylor Brenton EVP, Operations & R&D | Sale | 2,829 | $5.42 | $15,333.18 | View Details |
| Jul 2, 2026 | Bauerlein Alison Chief Operating Officer | Sale | 24,184 | $5.36 | $129,626.24 | View Details |
| Jul 1, 2026 | Badawi Paul Director | Sale | 28,684 | $5.42 | $155,467.28 | View Details |
| Jun 10, 2026 | Encrantz Staffan Director | Purchase | 14,100 | $4.88 | $68,793.90 | View Details |
| May 18, 2026 | Bauerlein Alison Chief Operating Officer | Sale | 12,728 | $5.12 | $65,167.36 | View Details |
32 more transactions available โ create a free account to see 12 months of history | ||||||
Upcoming Earnings
Scheduled earnings reports
No upcoming earnings scheduled
Past Earnings
Historical earnings results
EPS
EstimatedN/A
ActualN/A
Revenue
EstimatedN/A
ActualN/A
3 more earnings records available โ create a free account to see 12 months of history